Stocks · Korea 102940 KOSDAQ

Kolon Life Science

14,740원 +1.17% Market cap 1,930억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER7.37x
PBR0.33x
EPS2,001 KRW
BPS45,249 KRW
ROE4.51%
DPS0 KRW

Returns and 52-week range

1W+6.28%
1M+1.17%
3M-66.33%
6M-75.03%
1Y-56.23%
YTD-68.32%
52W high72,700원
52W low13,210원
From 52W high-79.74%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20221,924억16억21억0.8%
20231,246억-241억-307억-19.3%
20241,614억-221억-931억-13.7%
20252,090억176억250억8.4%
Quarterly
2024 4Q469억-32억-167억-6.9%
2025 1Q448억74,058,589원105억0.2%
2025 2Q530억13억-15억2.4%
2025 3Q665억189억255억28.4%
2025 4Q447억-27억-96억-6.0%
2026 1Q497억29억208억5.9%

Company

CEO이한국
Founded2000-04-21
Fiscal year end12
Website-
Address: 서울특별시 강서구 마곡동로 110 코오롱 One&Only 타워

Peers in the same sector

CompanyMarket capP/EP/B1M
영진약품1,955억—2.14-3.87%
한국유니온제약1,924억——+0.00%
녹십자웰빙1,958억19.331.72+1.40%
이연제약1,903억—0.85+3.33%
강스템바이오텍2,083억—3.03+1.61%
환인제약1,893억11.880.45-2.02%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Recent news

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.